Stratos Wealth Partners LTD. Sells 25,000 Shares of Myomo, Inc. (NYSEAMERICAN:MYO)

Stratos Wealth Partners LTD. reduced its stake in Myomo, Inc. (NYSEAMERICAN:MYO) by 50.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 25,000 shares of the company’s stock after selling 25,000 shares during the quarter. Stratos Wealth Partners LTD. owned approximately 0.08% of Myomo worth $161,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Barclays PLC purchased a new position in shares of Myomo during the third quarter valued at about $36,000. Rosalind Advisors Inc. grew its position in shares of Myomo by 13.4% during the third quarter. Rosalind Advisors Inc. now owns 3,021,391 shares of the company’s stock valued at $12,116,000 after purchasing an additional 356,392 shares in the last quarter. Jane Street Group LLC purchased a new position in shares of Myomo during the third quarter valued at about $65,000. GSA Capital Partners LLP grew its position in shares of Myomo by 60.8% during the third quarter. GSA Capital Partners LLP now owns 103,342 shares of the company’s stock valued at $414,000 after purchasing an additional 39,085 shares in the last quarter. Finally, Vontobel Holding Ltd. purchased a new position in shares of Myomo during the third quarter valued at about $90,000. 44.99% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Ascendiant Capital Markets lifted their price target on Myomo from $8.50 to $9.00 and gave the stock a “buy” rating in a research report on Tuesday, November 12th. HC Wainwright reiterated a “buy” rating and issued a $7.50 price target on shares of Myomo in a research report on Wednesday, November 13th. Finally, Craig Hallum lifted their price target on Myomo from $7.00 to $9.00 and gave the stock a “buy” rating in a research report on Friday, December 13th.

Myomo Stock Performance

NYSEAMERICAN MYO opened at $6.22 on Friday. Myomo, Inc. has a 12-month low of $2.51 and a 12-month high of $7.17. The firm has a market capitalization of $188.16 million, a price-to-earnings ratio of -27.04 and a beta of 1.68.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.